Curative’s transformation from pandemic testing to employer health insurance gives Wilson-Ciranna an unusual vantage point on growth, risk and operating finance. She explains why the company committed roughly $500 million to its insurance launch and how its zero-deductible, zero-copay model is designed to remove barriers that can discourage people from seeking preventive care or taking […]
1165: Building a Business That Stands on Its Own | Manu Diwakar, CFO, Virta Health
Nearly 90% of Americans suffer from metabolic disease, Manu Diwakar tells us, citing a recent McKinsey & Company study. For Diwakar, CFO of Virta Health, that statistic defines both the scale of the challenge and the clarity of the mission. Metabolic disease, he explains, includes type 2 diabetes, obesity, liver disease, kidney disease, heart disease,…
Listen to the Episode Below (0:49:20)
When Data and AI Reshape Precision Medicine
Jim Rogers applied lessons from Groupon’s rapid growth by steering Tempus toward disciplined expansion. He prioritized oncology as the core focus, deferring broader disease or international moves until sustainable, long-term growth could be assured—ensuring strategy aligned with impact without disrupting day-to-day operations. Now Watch the Complete Episode Featuring CFO Jim Rogers of Tempus AI Jim […]
1123: From Accounting Rigor to Strategic Leadership | Jim Rogers, CFO Tempus AI
The pivot began when Jim Rogers raised his hand. Groupon was shifting from mobile daily deals to a goods business in Europe, and—still early in his career—he volunteered to help lead the finance work. That step, he tells us, bridged his path from technical accounting into FP&A and set a pattern: seek out the build…
Listen to the Episode Below (0:38:16)